该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2017-05-02 AccNo: 0001437749-17-007686 Size: 50 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$凯姆布雷克斯(CBM)$ 内部交易: 2017-04-03,总裁 & CEO,KLOSK STEVEN M ,卖出,12000普通股, $54.58
$凯姆布雷克斯(CBM)$ 内部交易: 2017-04-03,总裁 & CEO,KLOSK STEVEN M ,期权,12000普通股, $5.72
$凯姆布雷克斯(CBM)$ DEF 14A - Other definitive proxy statements Filed: 2017-03-21 AccNo: 0001437749-17-004955 Size: 980 KB 网页链接
$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-03-10 AccNo: 0000932471-17-003485 Size: 48 KB 网页链接
$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0001144204-17-008686 Size: 54 KB 网页链接
$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-10 AccNo: 0000932471-17-001972 Size: 36 KB 网页链接
$凯姆布雷克斯(CBM)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-02-03 AccNo: 0001437749-17-001571 Size: 12 MB 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2017-02-03 AccNo: 0001437749-17-001569 Size: 500 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 美东时间 2017-02-03 盘前 披露财报,预期EPS 1.05 网页链接